InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Nassif David W., Chief Financial Officer. Director active across 1 companies, notably Sio Gene Therapies Inc.. Aggregated, 2 disclosures have been recorded. The latest transaction was disclosed on 8 December 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
017,534 shares0
Common Stock
SEC:0001636050-21-000099·
017,534 shares0
Common Stock
SEC:0001636050-21-000099:0·
2 of 2 declarations
About Nassif David W.
Nassif David W. is the Chief Financial Officer at Sio Gene Therapies Inc. He is responsible for the company's financial management, overseeing financial planning and analysis. David plays a key role in financial strategy and regulatory compliance, contributing to the company's growth.
